Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

RNA-interference effectors and their delivery.

D Putnam1, A Doody

  • 1Department of Biomedical Engineering and the School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, USA.

Critical Reviews in Therapeutic Drug Carrier Systems
|September 6, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of rumen-protected choline and monensin on milk production and metabolism of periparturient dairy cows.

Journal of dairy science·2006
Same author

Inhibition of transferrin recycling and endosome tubulation by phospholipase A2 antagonists.

The Journal of biological chemistry·2001
Same author

Monocharged inhibitors of mast cell tryptase derived from potent and selective dibasic inhibitors.

Bioorganic & medicinal chemistry letters·2001
Same author

Accelerated discovery of synthetic transfection vectors: parallel synthesis and screening of a degradable polymer library.

Journal of the American Chemical Society·2001
Same author

Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA.

Journal of controlled release : official journal of the Controlled Release Society·2001
Same author

Dibasic inhibitors of human mast cell tryptase. Part 3: identification of a series of potent and selective inhibitors containing the benzamidine functionality.

Bioorganic & medicinal chemistry letters·2001
Same journal

Unveiling the Potential of Drug Delivery Systems for Tyrosine Kinase Inhibitors in the Treatment of Neovascular Eye Diseases.

Critical reviews in therapeutic drug carrier systems·2026
Same journal

Investigation of Bioinspired Nanocurcumin Composites for Antibacterial Applications.

Critical reviews in therapeutic drug carrier systems·2026
Same journal

Advances in the Preparation of Lipid-Based Nanotechnologies: Expanding the Horizons of Therapeutic Applications.

Critical reviews in therapeutic drug carrier systems·2026
Same journal

Nano Lipid Carriers (NLCs): Potential and Promises in Drug Delivery.

Critical reviews in therapeutic drug carrier systems·2026
Same journal

CpG ODNs: Precision Immunotherapy and Recent Trends in Nano-Enabled Nucleotide Delivery.

Critical reviews in therapeutic drug carrier systems·2026
Same journal

Plant-Based Exosomes: Insights and Therapeutic Applications.

Critical reviews in therapeutic drug carrier systems·2026
See all related articles

RNA-interference (RNAi) offers a way to treat diseases by reducing protein expression. Effective delivery of RNAi effectors, like small interfering RNA, is crucial and often requires synthetic polymer systems.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Drug Delivery

Background:

  • RNA-interference (RNAi) is a natural biological process for gene silencing.
  • RNAi therapeutics aim to reduce disease-causing protein expression.
  • Current RNAi effectors face delivery challenges due to their macromolecular and polyanionic nature.

Purpose of the Study:

  • To review the mechanism of RNA-interference.
  • To discuss the challenges and strategies for delivering RNAi effectors.
  • To highlight the role of synthetic polymer-based delivery systems in RNAi therapy.

Main Methods:

  • Review of existing literature on RNAi mechanisms.
  • Analysis of RNAi effector properties and delivery requirements.
  • Examination of synthetic polymer-based delivery vehicles for RNAi.

Related Experiment Videos

Main Results:

  • RNAi effectors like small interfering RNA (siRNA) and small hairpin RNA (shRNA) can be designed to target specific mRNA.
  • The efficacy of RNAi effectors is limited by poor cellular uptake and stability.
  • Synthetic polymers offer promising solutions for protecting and delivering RNAi effectors.

Conclusions:

  • RNAi is a potent therapeutic strategy for various diseases.
  • Efficient delivery systems are essential for successful RNAi-based treatments.
  • Synthetic polymer-based systems represent a key advancement in overcoming RNAi delivery hurdles.